Showing results (1-10 of 3) with videos related to
Sort By:
Pageof 1
Lung|June 7, 2022
A Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability, and Pharmacokinetics of 3 Weeks of Orally Administered Gefapixant in Healthy Younger and Older AdultsJesse Nussbaum, Azher Hussain, Anthony Ford, et al.The European Respiratory Journal|January 18, 2020
Gefapixant in two randomised dose-escalation studies in chronic coughJaclyn A Smith, Michael M Kitt, Peter Butera, et al.Journal of Clinical Pharmacology|April 23, 2024
Single- and Multiple-Dose Pharmacokinetics of Gefapixant (MK-7264), a P2X3 Receptor Antagonist, in Healthy AdultsJesse C Nussbaum, Azher Hussain, Peter Butera, et al.Pageof 1